Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes.
Lappas
M
M
Department of Obstetrics and Gynaecology, The University of Melbourne and Mercy Perinatal Research Center, Mercy Hospital for Women, 126 Clarendon Street, East Melbourne, Victoria, Australia 3002. mlappas@unimelb.edu.au
Permezel
M
M
Ho
P W
PW
Moseley
J M
JM
Wlodek
M E
ME
Rice
G E
GE
D000111:Acetylcysteine / Q000494:pharmacology; D000328:Adult; D000650:Amnion / Q000187:drug effects* / Q000378:metabolism; D002478:Cells, Cultured; D002823:Chorion / Q000187:drug effects* / Q000378:metabolism; D002839:Chromans / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology; D008024:Ligands; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D047495:PPAR gamma / Q000494:pharmacology*; D044162:Parathyroid Hormone-Related Protein / Q000378:metabolism*; D011247:Pregnancy; D015230:Prostaglandin D2 / Q000031:analogs & derivatives* / Q000494:pharmacology; D012460:Sulfasalazine / Q000494:pharmacology; D045162:Thiazolidinediones / Q000494:pharmacology; D000077288:Troglitazone
C097240:15-deoxy-delta(12,14)-prostaglandin J2; D002839:Chromans; D007155:Immunologic Factors; D008024:Ligands; D016328:NF-kappa B; D047495:PPAR gamma; D044162:Parathyroid Hormone-Related Protein; D045162:Thiazolidinediones; D012460:Sulfasalazine; D000077288:Troglitazone; D015230:Prostaglandin D2; D000111:Acetylcysteine